ICON PLC

About ICON PLC

ICON plc is a global Clinical Research Organization (CRO) focused on advancing clinical research and drug development. The company aims to expand possibilities for customers, partners, and patients by providing innovative solutions and technologies across various phases of clinical trials, from early phase to post-marketing.

Products & Services

Blended Solutions:Bespoke, seamless solutions to meet unique sponsor challenges in pharmaceuticals.

Outcome Measures:A multi-faceted approach to identifying, selecting, and implementing evidence-based measures that matter to patients.

Biotech Services:Full service outsourcing and flexible support for biotech needs, including due diligence and asset valuation.

Cardiac Safety Solutions:End-to-end cardiac safety solutions, including ECG, event monitoring, and various studies.

Early Clinical and Bioanalytical Solutions:Innovative early clinical solutions to advance drug development strategies.

Site & Patient Solutions:Transforming recruitment through patient-centric trials and real-world, real-time data.

Market Access:Expertise in mission-critical pricing, market access, and reimbursement.

Specialty Laboratory Solutions:Supporting precision medicine programs across all phases of drug diagnostic co-development.

Specialties

Clinical Research Organization (CRO) Drug Development Decentralized Clinical Trials Cardiac Safety Solutions Early Clinical and Bioanalytical Solutions Real World Intelligence Regulatory Affairs Therapeutic Areas (Cardiovascular, Oncology, Infectious Diseases, Rare & Orphan Diseases, etc.) Digital Health Technologies Artificial Intelligence (AI) in Healthcare

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Bond Offering (Senior Secured Notes) T: - FT: Bond Offering (Senior Secured Notes)	A: 2000000000 MR: - FA: USD 2 billion FAN: 2000000000	D: 2024-04-30 FD: 2024-04-30	-

Bond Offering (Senior Secured Notes) Latest

2024-04-30

$2.0B

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

H

Hans Werner Voss

B

Barry Balfe

Chief Executive Officer

N

Nigel Clerkin

Chief Financial Officer

U

Ute Berger

Chief Medical Officer and President, ICON Development Solutions

J

Jonathan Harris

President, ICON Pharma Solutions

T

Tony Southers

President, ICON Strategic Solutions

View 13 more team members with Pro

Unlock Full Team Directory

Recent News

ICON PLC Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised